A study identified racial and ethnic disparities in survival among newly diagnosed patients with childhood cancers in the U.S., with area-level socioeconomic status and health insurance contributing to these disparities.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
